Brief: Hookipa Pharma Announces Leadership Changes To Intensify Focus On HB-200
July 22 (Reuters) - Arvinas Inc ARVN.O :
* HOOKIPA PHARMA ANNOUNCES LEADERSHIP CHANGES TO INTENSIFY
FOCUS
ON HB-200
* HOOKIPA PHARMA INC - DR. MALTE PETERS NAMED CEO AT HOOKIPA
* HOOKIPA PHARMA INC - TERRY COELHO APPOINTED EVP AND CFO AT
HOOKIPA
* HOOKIPA PHARMA : SEAN CASSIDY APPOINTED TO BOARD OF
DIRECTORS
Source text for Eikon: ID:nGNX5pWq9g
Further company coverage: ARVN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arvinas
See all newsBrief: Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Arvinas Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Arvinas - Pfizer, And Rigel Receive Hart-Scott-Rodino Clearance For License Agreement On June 11, 2026
Brief: Arvinas - Announces Re-Prioritization Of Portfolio Following Strategic Review - SEC Filing
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology